Literature DB >> 14957241

The clinical use of norepinephrine in the treatment of shock accompanying myocardial infarction and other conditions.

G S KURLAND, M MALACH.   

Abstract

Entities:  

Keywords:  ARTERENOL/therapeutic use; MYOCARDIAL INFARCT/complications; SHOCK

Mesh:

Substances:

Year:  1952        PMID: 14957241     DOI: 10.1056/NEJM195209112471102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  STUDIES IN CLINICAL SHOCK AND HYPOTENSION. II. HEMODYNAMIC EFFECTS OF NOREPINEPHRINE AND ANGIOTENSIN.

Authors:  J N COHN; M H LURIA
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

2.  Spontaneous rupture of the esophagus.

Authors:  G H BUNCH
Journal:  Ann Surg       Date:  1957-06       Impact factor: 12.969

3.  Treatment of severe shock by noradrenaline; report of four cases.

Authors:  I E GILMOUR
Journal:  Br Med J       Date:  1955-11-19

4.  [More recent results on the pathogenesis of pulmonary edema].

Authors:  M D ALTSCHULE
Journal:  Klin Wochenschr       Date:  1956-02-15

5.  Noradrenaline in shock due to visceral perforation.

Authors:  D D DAVIES
Journal:  Br Med J       Date:  1957-02-02

6.  Total and peripheral blood flow in acute myocardial infarction.

Authors:  G J LEE
Journal:  Br Heart J       Date:  1957-01

7.  Acute peripheral circulatory failure in surgical cases; treatment with 1-noradrenaline.

Authors:  H D RITCHIE
Journal:  Br Med J       Date:  1956-02-18

8.  The effect of L-norepinephrine on cardiac output in the anesthetized dog during graded hemorrhage.

Authors:  J P GILMORE; C M SMYTHE; S W HANDFORD
Journal:  J Clin Invest       Date:  1954-06       Impact factor: 14.808

9.  L-Noradrenaline in treatment of shock in cardiac infarction.

Authors:  K S SMITH; A GUZ
Journal:  Br Med J       Date:  1953-12-19

10.  Treatment of cardiogenic shock by prolonged administration of norepinephrine.

Authors:  A ENGLISH
Journal:  Can Med Assoc J       Date:  1953-06       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.